These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29944701)

  • 1. Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
    Mbu ET; Sauter F; Zoufaly A; Bronsvoort BMC; Morgan KL; Noeske J; Abena JF; Sander MS
    PLoS One; 2018; 13(6):e0199634. PubMed ID: 29944701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
    Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
    PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: need for enhanced screening approach.
    Henostroza G; Harris JB; Chitambi R; Siyambango M; Turnbull ER; Maggard KR; Krüüner A; Kapata N; Reid SE
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1033-9. PubMed ID: 27393536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
    Yoon C; Semitala FC; Atuhumuza E; Katende J; Mwebe S; Asege L; Armstrong DT; Andama AO; Dowdy DW; Davis JL; Huang L; Kamya M; Cattamanchi A
    Lancet Infect Dis; 2017 Dec; 17(12):1285-1292. PubMed ID: 28847636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Yield of Different Diagnostic Tests for Tuberculosis among People Living with HIV in Western Kenya.
    Cavanaugh JS; Modi S; Musau S; McCarthy K; Alexander H; Burmen B; Heilig CM; Shiraishi RW; Cain K
    PLoS One; 2016; 11(3):e0152364. PubMed ID: 27023213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(®) MTB/RIF.
    Adelman MW; Tsegaye M; Kempker RR; Alebachew T; Haile K; Tesfaye A; Aseffa A; Blumberg HM
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1197-203. PubMed ID: 26459533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
    PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic screening for tuberculosis among hospital outpatients in Cameroon: The role of screening and testing algorithms to improve case detection.
    Sander MS; Laah SN; Titahong CN; Lele C; Kinge T; de Jong BC; Abena JF; Codlin AJ; Creswell J
    J Clin Tuberc Other Mycobact Dis; 2019 May; 15():100095. PubMed ID: 31720422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    BMC Med; 2013 Oct; 11():231. PubMed ID: 24168211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sensitivity and Specificity of Loop-Mediated Isothermal Amplification (LAMP) Assay for Tuberculosis Diagnosis in Adults with Chronic Cough in Malawi.
    Nliwasa M; MacPherson P; Chisala P; Kamdolozi M; Khundi M; Kaswaswa K; Mwapasa M; Msefula C; Sohn H; Flach C; Corbett EL
    PLoS One; 2016; 11(5):e0155101. PubMed ID: 27171380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A descriptive study of smear negative pulmonary tuberculosis in a high HIV burden patient's population in North Central Nigeria.
    Tiamiyu AB; Iliyasu G; Dayyab FM; Habib ZG; Tambuwal SH; Animashaun AO; Galadanci H; Bwala SA; Lawson L; Habib AG
    PLoS One; 2020; 15(9):e0238007. PubMed ID: 32870914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.